Abstract
Background: Radiotherapy treatment for cervical cancer (CC) often induces side effects, including inflammation, dryness, dyspareunia. Considering its key role in the healing process, hyaluronic acid (HA) could be useful for the completion of radiotherapy. Objectives: The aim of this work was to evaluate the ability of HA to reduce the onset of side effects due to radiotherapy. Materials and Methods: In total, 180 women undergoing radiotherapy were randomized into two arms: controls and those treated with vaginal suppositories containing low-molecular-weight HA from day 1 of radiotherapy. The study lasted 5 weeks and was characterized by three visits: at baseline (T0), 15 days later (T1), and at the end of the radiotherapy cycle (T2). The onset of side effects, pain, safety, efficacy, acceptability of treatment, and compliance to the therapy were evaluated. Results: Patients in the control arm reported the onset and worsening of all symptoms with a moderate or severe grade at T2, whereas in the treatment arm almost 90% of patients reported the absence of symptoms or a mild grade. All patients in the treatment arm referred a lower intensity of pain on a visual analog scale compared with the control arm at T2 (6.85 ± 0.94 vs. 1.88 ± 1.02). Conclusions: HA was able to help vaginal mucosa healing during radiotherapy in patients with CC.
Journal Section:
Research Article
References
1.
International Agency for Research on Cancer
. World Health Organization.
Globocan 2012
. Available from: http://gco.iarc.fr/today2.
Hillemanns
P
, Soergel
P
, Hertel
H
, Jentschke
M
. Epidemiology and Early Detection of Cervical Cancer
. Oncol Res Treat
. 2016
;39
(9
):501
–6
.
[PubMed]
2296-52703.
Javier
MG
, Sastre-Garau
X
. Uterine cervix carcinoma: recent biological data and update for improving follow-up and treatment
. Isr Med Assoc J
. 2012
Nov
;14
(11
):700
–4
.
[PubMed]
1565-10884.
Schofield
P
, Juraskova
I
, Bergin
R
, Gough
K
, Mileshkin
L
, Krishnasamy
M
, et al.. A nurse- and peer-led support program to assist women in gynaecological oncology receiving curative radiotherapy, the PeNTAGOn study (peer and nurse support trial to assist women in gynaecological oncology): study protocol for a randomised controlled trial
. Trials
. 2013
Feb
;14
(1
):39
.
[PubMed]
1745-62155.
Laliscia
C
, Delishaj
D
, Fabrini
MG
, Gonnelli
A
, Morganti
R
, Perrone
F
, et al.. Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: is local therapy with hyaluronic acid of clinical benefit
. J Contemp Brachytherapy
. 2016
Dec
;8
(6
):512
–7
.
[PubMed]
1689-832X6.
Deorukhkar
A
, Krishnan
S
. Targeting inflammatory pathways for tumor radiosensitization
. Biochem Pharmacol
. 2010
Dec
;80
(12
):1904
–14
.
[PubMed]
0006-29527.
Domoney
C
. Treatment of vaginal atrophy
. Womens Health (Lond)
. 2014
Mar
;10
(2
):191
–200
.
[PubMed]
1745-50658.
Laurent
TC
, Laurent
UB
, Fraser
JR
. The structure and function of hyaluronan: an overview
. Immunol Cell Biol
. 1996
Apr
;74
(2
):A1
–7
.
[PubMed]
0818-96419.
Jiang
D
, Liang
J
, Noble
PW
. Hyaluronan as an immune regulator in human diseases
. Physiol Rev
. 2011
Jan
;91
(1
):221
–64
.
[PubMed]
0031-933310.
Termeer
C
, Benedix
F
, Sleeman
J
, Fieber
C
, Voith
U
, Ahrens
T
, et al.. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4
. J Exp Med
. 2002
Jan
;195
(1
):99
–111
.
[PubMed]
0022-100711.
Nakamura
K
, Yokohama
S
, Yoneda
M
, Okamoto
S
, Tamaki
Y
, Ito
T
, et al.. High, but not low, molecular weight hyaluronan prevents T-cell-mediated liver injury by reducing proinflammatory cytokines in mice
. J Gastroenterol
. 2004
;39
(4
):346
–54
.
[PubMed]
0944-117412.
Chang
EJ
, Kim
HJ
, Ha
J
, Kim
HJ
, Ryu
J
, Park
KH
, et al.. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4
. J Cell Sci
. 2007
Jan
;120
(Pt 1
):166
–76
.
[PubMed]
0021-953313.
Kavasi
RM
, Berdiaki
A
, Spyridaki
I
, Corsini
E
, Tsatsakis
A
, Tzanakakis
G
, et al.. HA metabolism in skin homeostasis and inflammatory disease
. Food Chem Toxicol
. 2017
Mar
;101
:128
–38
.
[PubMed]
0278-691514.
Costantino
D
, Guaraldi
C
. Effectiveness and safety of vaginal suppositories for the treatment of the vaginal atrophy in postmenopausal women: an open, non-controlled clinical trial
. Eur Rev Med Pharmacol Sci
. 2008
Nov-Dec
;12
(6
):411
–6
.
[PubMed]
1128-360215.
Ross
C
, Harrison
E
. Vitamin A: Nutritional Aspects of Retinoids and Carotenoids. In: Zempleni
J
, Suttie
J
, Gregory
J
3rd, Stover
P
, editors. Handbook of Vitamins
. Boca Raton
: CRC Press, Taylor & Francis Group
; 2012
. pp. 1
–40
.16.
Tammi
R
, Ripellino
JA
, Margolis
RU
, Maibach
HI
, Tammi
M
. Hyaluronate accumulation in human epidermis treated with retinoic acid in skin organ culture
. J Invest Dermatol
. 1989
Mar
;92
(3
):326
–32
.
[PubMed]
0022-202X17.
National Comprensive Cancer Network
. National Comprensive Cancer Network Guidelines
2016
. Available from: https://www.tri-kobe.org/nccn/guideline18.
Eastern Cooperative Oncology Group
. Eastern Cooperative Oncology Group Performance Status (ECOG-PS) Scale 2017
. Available from: www.ecog-acrin.org19.
Somashekhar
SP
, Ashwin
KR
. Management of Early Stage Cervical Cancer
. Rev Recent Clin Trials
. 2015
;10
(4
):302
–8
.
[PubMed]
1574-887120.
Naik
A
, Gurjar
OP
, Gupta
KL
, Singh
K
, Nag
P
, Bhandari
V
. Comparison of dosimetric parameters and acute toxicity of intensity-modulated and three-dimensional radiotherapy in patients with cervix carcinoma: A randomized prospective study
. Cancer Radiother
. 2016
Jul
;20
(5
):370
–6
.
[PubMed]
1278-321821.
Radiation Therapy Oncology Group and European Organization for Research and Treatment of Cancer ER
. Routine Adverse Events Reporting Questions
2017
. Available from: https://www.rtog.org/ResearchAssociates/AdverseEventReporting.aspx22.
McCormack
HM
, Horne
DJ
, Sheather
S
. Clinical applications of visual analogue scales: a critical review
. Psychol Med
. 1988
Nov
;18
(4
):1007
–19
.
[PubMed]
0033-291723.
Roszak
A
, Wareńczak-Florczak
Z
, Bratos
K
, Milecki
P
. Incidence of radiation toxicity in cervical cancer and endometrial cancer patients treated with radiotherapy alone versus adjuvant radiotherapy
. Rep Pract Oncol Radiother
. 2012
Sep
;17
(6
):332
–8
.
[PubMed]
1507-136724.
Dinicola
S
, Pasta
V
, Costantino
D
, Guaraldi
C
, Bizzarri
M
. Hyaluronic acid and vitamins are effective in reducing vaginal atrophy in women receiving radiotherapy
. Minerva Ginecol
. 2015
Dec
;67
(6
):523
–31
.
[PubMed]
1827-165025.
Dean
A
, Sullivan
K
, Soe
M
. OpenEpi: Open Source Epidemiologic Statistics for Public Health; Version 3.01. 2013
. Available from: www.OpenEpi.com26.
Derzko
C
, Elliott
S
, Lam
W
. Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy
. Curr Oncol
. 2007
Dec
;14
(S1
Suppl 1
):S20
–40
.
[PubMed]
1198-005227.
Kishi
K
, Mabuchi
Y
, Sonomura
T
, Shirai
S
, Noda
Y
, Sato
M
, et al.. Eradicative brachytherapy with hyaluronate gel injection into pararectal space in treatment of bulky vaginal stump recurrence of uterine cancer
. J Radiat Res (Tokyo)
. 2012
Jul
;53
(4
):601
–7
.
[PubMed]
0449-306028.
Pavicic
T
, Gauglitz
GG
, Lersch
P
, Schwach-Abdellaoui
K
, Malle
B
, Korting
HC
, et al.. Efficacy of cream-based novel formulations of hyaluronic acid of different molecular weights in anti-wrinkle treatment
. J Drugs Dermatol
. 2011
Sep
;10
(9
):990
–1000
.
[PubMed]
1545-9616© 2019 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2019
You do not currently have access to this content.
